Market Cap : 163.6 B | Enterprise Value : 194.4 B | PE Ratio : 27.25 | PB Ratio : 5.18 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:
We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.
Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.
As of today (2022-07-04), Bristol-Myers Squibb Co's share price is $76.84. Bristol-Myers Squibb Co's GF Value is $74.10. Therefore, Bristol-Myers Squibb Co's Price-to-GF-Value for today is 1.04.
Based on the relationship between the current stock price and the GF Value, GuruFocus believes Bristol-Myers Squibb Co is Fairly Valued.
Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:
Posssible Evaluations | All-in-One Screener Examples (2) |
Possible Value Trap, Think Twice (1) | Predictable Companies that possibly be Value Traps |
Significantly Overvalued | Predictable Companies which are Significantly Overvalued |
Modestly Overvalued | Predictable Companies which are Modestly Overvalued |
Fairly Valued | Predictable High Quality Companies which are Fairly Valued |
Modestly Undervalued (3) | Predictable High Quality Companies which are Modestly Undervalued |
Significantly Undervalued (3) | Predictable High Quality Companies which are Significantly Undervalued |
(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.
(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.
(3) There is only a sufficient margin of safety when the stock is undervalued.
Bristol-Myers Squibb Co's Price-to-GF-Value for today is calculated as
Price-to-GF-Value | = | Share Price | / | GF Value |
= | 76.84 | / | 74.10 | |
= | 1.04 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Vousden Karen H | director | 345 PARK AVENUE NEW YORK NY 10154 |
Samuels Theodore R. Ii | director | 1990 E. GRAND AVE. EL SEGUNDO CA 90245 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Paliwal Dinesh C | director | 5454 W 110TH STREET OVERLAND PARK KS 66211 |
Rice Derica W | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Emmens Matthew | director | C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139 |
Bertolini Robert J | director | C/O SCHERING PLOUGH CORP 2000 GALLOPING HILL RD KENILWORTH NJ 070333 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Yale Phyllis R | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: YALE PHYLLIS R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Arduini Peter J | director | 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 |
Santiago Karen Murphy | officer: SVP & Controller | BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCE LINE ROAD PRINCETON NJ 08540 |
Caforio Giovanni | director, officer: Chairman and CEO | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCELINE ROAD LAWRENCEVILLE NJ 08543 |
Eid Joseph | officer: SVP,Head Glob. Medical Affairs | BRISTOL-MYERS SQUIBB COMPANY 3401 PRINCETON PIKE LAWRENCEVILLE NJ 08648 |
Leung Sandra | officer: EVP, General Counsel | C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164 |
From GuruFocus
Other Sources
By Zacks 2022-03-28
By Zacks 2022-04-05
By Zacks 2022-03-16
By Zacks 2022-04-05
By tipranks.com 2022-03-21
By Zacks 2022-03-31
By Zacks 2022-04-04
By Zacks 2022-03-21
By Zacks 2022-04-05
By Zacks 2022-03-28
By Zacks 2022-03-30
By Fool 2022-03-30
By Zacks 2022-03-16